Histamine-induced adherence and migration of equine eosinophils

American Journal of Veterinary Research

Volumn 59, Issue 9, 1998, Pages 1153-1159

  Foster, A P ^a,b   Cunningham, F M ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; CHLORPHENIRAMINE; FIBRONECTIN; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; HOMING RECEPTOR; INTEGRIN; MEPYRAMINE; MONOCLONAL ANTIBODY; PLASTIC; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL; ARTICLE; BLOOD; CELL ADHESION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; EOSINOPHIL; FEMALE; HORSE; IMMUNOLOGY; MALE; METABOLISM; NEUTROPHIL CHEMOTAXIS; SURFACE PROPERTY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD18; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; CHLORPHENIRAMINE; EOSINOPHILS; FEMALE; FIBRONECTINS; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HORSES; INTEGRIN ALPHA4BETA1; INTEGRINS; MALE; PLASTICS; PYRILAMINE; RECEPTORS, HISTAMINE; RECEPTORS, LYMPHOCYTE HOMING; SURFACE PROPERTIES;

EID: 0032161679     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Klei TR, Chapman MR, Dennis VA. Role of the eosinophil in serum-mediated adherence of equine leucocytes to infective larvae of Strongylus vulgaris. J Parasitol 1992;78:477-484.
2. Piller K, Portmann P. Isolation and characterization of four basic proteins from horse eosinophilic granules. Biochem Biophys Res Comm 1993;192:373-380.
3. 2-halide system and granule basic proteins. J Immunol 1989;143:239-244.
4. Foster AP, McCabe PJ, Sanjar S, et al. Agonist-induced adherence of equine eosinophils to fibronectin. Vet Immunol Immunopathol 1997;56:205-220.
5. Foster AP, Cunningham FM. Differential superoxide anion generation by equine eosinophils and neutrophils. Vet Immunol Immunopathol 1997;59:225-237.
6. Asmis R, Jorg A. Calcium-ionophore-induced formation of platelet-activating factor and leukotrienes by horse eosinophils: a comparative study. Eur J Biochem 1990;187:475-480.
7. Foster AP, Lees P, Cunningham FM. Actions of PAF receptor antagonists in horses with the allergic skin disease sweet itch. Inflamm Res 1995;44:412-417.
8. Foster AP, Lees P, Cunningham FM. Platelet activating factor mimics antigen-induced cutaneous inflammatory responses in sweet itch horses. Vet Immunol Immunopathol 1995;44:115-128.
9. 2- in response to physiologic soluble stimuli is differentially modulated by extracellular matrix components and endothelial cells. J Immunol 1991;147:613-620.
10. Sanderson CJ. Interleukin-5, eosinophils and disease. Blood 1992;79:3101-3109.
11. Riek RF. Studies on allergic dermatitis (Queensland itch) of the horse: the origin and significance of histamine in the blood and its distribution in the tissues. Aust J Agric Res 1955;6:161-170.
12. 4. zymosan activated serum, histamine, tabanid extract, and n-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils. Can J Vet Res 1990;54:400-404.
13. Foster AP, Lees P, Cunningham FM. Platelet activating factor is a mediator of equine neutrophil and eosinophil migration in vitro. Res Vet Sci 1992;53:223-229.
14. Foster AP, Cunningham FM, Lees P. Inflammatory effects of platelet activating factor (PAF) in equine skin. Equine Vet J 1992;24: 208-214.
15. Hill SJ. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev 1990;42:45-83.
16. Teixeira MM, Reynia S, Robinson M, et al. Role of CD18 in the accumulation of eosinophils and neutrophils and local oedema formation in inflammatory reactions in guinea pig skin. Br J Pharmacol 1994;111:811-818.
17. Anwar ARE, McKean JR, Smithers SR, et al. Human eosinophil-and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides. J Immunol 1980;124:1122-1129.
18. Bryant RE, Sutcliffe MC. The effect of 3′,5′-adenosine monophosphate on granulocyte adhesion. J Clin Invest 1974;54:1241-1244.
19. Robinson BV. Histamine receptor agonists and antagonists on granulocyte adherence. J Pharm Pharmacol 1982;34:458-461.
20. Watanabe M, Yagi M, Omata M, et al. Stimulation of neutrophil adherence to vascular endothelial cells by histamine and thrombin and its inhibition by PAF antagonists and dexamethasone. Br J Pharmacol 1991;102:239-245.
21. Anwar ARE, Moqbel R, Walsh GM, et al. Adhesion to fibronectin prolongs eosinophil survival. J Exp Med 1993;177:839-843.
22. Anwar ARE, Kay AB. The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors. Nature 1977;269:522-524.
23. Clark RAF, Gallin JI, Kaplan AP. The selective eosinophil chemotactic activity of histamine. J Exp Med 1975;142:1462-1476.
24. Rabier M, Damon M, Chanez P, et al. Neutrophil chemotactic activity of PAF, histamine and neuromediators in bronchial asthma. J Lipid Mediators 1991;4:265-275.
25. Turnbull LW, Kay AB. Eosinophils and mediators of anaphylaxis: histamine and imidazole acetic acid as chemotactic agents for human eosinophil leucocytes. Immunology 1976;31:797-802.
26. Clark RAF, Sandler JA, Gallin JI et al. Histamine modulation of eosinophil migration. J Immunol 1977;118:137-145.
27. 1-receptor dependence of histamine-induced enhancement of human eosinophil C3b rosettes. Clin Exp Immunol 1980;42:196-199.
28. Raible DG, Lenahan T, Fayvilevich Y, et al. Pharmacologic characterisation of a novel histamine receptor on human eosinophils. Am J Resp Crit Care Med 1994;149:1506-1511.